NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 32 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $456,000 | -3.0% | 337,000 | 0.0% | 0.06% | -1.5% |
| Q4 2020 | $470,000 | +1.5% | 337,000 | 0.0% | 0.07% | -17.5% |
| Q3 2020 | $463,000 | -17.3% | 337,000 | 0.0% | 0.08% | -11.1% |
| Q2 2020 | $560,000 | +29.6% | 337,000 | 0.0% | 0.09% | +28.6% |
| Q1 2020 | $432,000 | -16.3% | 337,000 | 0.0% | 0.07% | +34.6% |
| Q4 2019 | $516,000 | +11.9% | 337,000 | 0.0% | 0.05% | +10.6% |
| Q3 2019 | $461,000 | +4.3% | 337,000 | 0.0% | 0.05% | +9.3% |
| Q2 2019 | $442,000 | -2.9% | 337,000 | 0.0% | 0.04% | -4.4% |
| Q1 2019 | $455,000 | +60.8% | 337,000 | +42.2% | 0.04% | +45.2% |
| Q4 2018 | $283,000 | -30.0% | 237,000 | 0.0% | 0.03% | -11.4% |
| Q3 2018 | $404,000 | +18.1% | 237,000 | 0.0% | 0.04% | +16.7% |
| Q2 2018 | $342,000 | – | 237,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |